| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC | 20% | 0% | $190,117,660 | +$181,455,120 | 8,713,000 | +2095% | Fairmount Funds Management LLC | 09 Feb 2026 |
| Venrock Healthcare Capital Partners III, L.P. | 6% | $78,630,443 | 3,603,595 | Venrock Healthcare Capital Partners III, L.P. | 09 Feb 2026 | |||
| FMR LLC | 15% | $6,650,364 | 238,878 | FMR LLC | 28 Nov 2025 | |||
| Jain Global LLC | 7.5% | $2,630,750 | 120,566 | Jain Global LLC | 31 Dec 2025 | |||
| Paramora Holding LLC | 7.5% | $3,494,922 | 120,473 | Paramora Holding LLC | 10 Nov 2025 | |||
| Paragon Therapeutics, Inc. | 7.5% | $3,494,922 | 120,473 | Paragon Therapeutics, Inc. | 10 Nov 2025 | |||
| Point72 Asset Management, L.P. | 6.3% | $372,164 | 100,001 | Point72 Asset Management, L.P. | 12 Nov 2025 |
As of 31 Dec 2025, 17 institutional investors reported holding 1,107,855 shares of Galecto, Inc. - Common Stock, $0.00001 par value per share (GLTO). This represents 1.8% of the company’s total 60,059,917 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1,107,855 | $25,491,709 | +$21,929,226 | $23.01 | 17 |
| 2025 Q3 | 170,205 | $633,327 | +$144,879 | $3.72 | 12 |
| 2025 Q2 | 132,660 | $451,146 | -$30,019 | $3.41 | 8 |
| 2025 Q1 | 142,568 | $441,959 | +$1,278 | $3.10 | 10 |
| 2024 Q4 | 142,062 | $660,654 | +$59,803 | $4.65 | 10 |
| 2024 Q3 | 128,626 | $1,562,807 | +$1,556,853 | $12.15 | 9 |